Bahram Valamehr, Chief Development Officer at FATE THERAPEUTICS INC (FATE), sold 11,400 shares at $20.69 ($236K) on 2020-01-08, disclosed to the SEC on 2020-01-10.
Open-market sale of $236k FATE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.69 | 5,700 | $118K | 50.0% |
| 2 | $20.69 | 5,700 | $118K | 50.0% |
| Total | $20.69 avg | 11,400 | $236K | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |